CareMetx Strengthens Leadership Team with Appointment of Brian Flaherty as Chief Commercial Officer
CareMetx enhances its leadership by appointing Brian Flaherty as Chief Commercial Officer, aiming to improve patient access to specialty therapies through strategic commercial initiatives.
CareMetx, a technology-enabled services company focused on facilitating patient access to specialty therapies, has announced the appointment of Brian Flaherty as its new Chief Commercial Officer. Flaherty's role will involve steering the company's commercial strategy, fostering collaborations with pharmaceutical manufacturers, providers, and strategic partners to enhance patient support services and expedite therapy access.
With over two decades of experience in healthcare, life sciences, and data-driven innovation, Flaherty's expertise is expected to be pivotal in addressing the complexities of patient access programs. His previous role as Vice President of Real-World Data and Evidence at Cardinal Health’s Specialty Networks Solutions division saw him leading initiatives that significantly improved patient outcomes in various therapeutic areas.
This leadership transition also sees Shabbir Ahmed moving to the position of Chief Growth Officer, where he will concentrate on developing strategic partnerships and expanding CareMetx's partner ecosystem. Flaherty expressed enthusiasm about joining CareMetx, highlighting the company's potential to tackle persistent healthcare access challenges through unified, flexible solutions that streamline data exchange among stakeholders.
Jim Rowe, CEO of CareMetx, emphasized the timeliness of Flaherty's appointment, noting the increasing complexity of access programs and the demand for partners capable of merging advanced technology with personalized service. Flaherty's leadership is anticipated to drive CareMetx's commercial strategy forward, reinforcing the company's commitment to simplifying provider workflows and enhancing patient and care team experiences.
CareMetx's initiative underlines its dedication to leveraging technology and leadership to overcome barriers in specialty therapy access, ensuring a more efficient and supportive healthcare ecosystem for patients and providers alike.